[go: up one dir, main page]

NO975634L - Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater - Google Patents

Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater

Info

Publication number
NO975634L
NO975634L NO975634A NO975634A NO975634L NO 975634 L NO975634 L NO 975634L NO 975634 A NO975634 A NO 975634A NO 975634 A NO975634 A NO 975634A NO 975634 L NO975634 L NO 975634L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparations
tiludronate
preparation
hydrates
stable
Prior art date
Application number
NO975634A
Other languages
English (en)
Other versions
NO975634D0 (no
Inventor
William Rocco
Sharon M Laughlin
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO975634D0 publication Critical patent/NO975634D0/no
Publication of NO975634L publication Critical patent/NO975634L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3865—Polyphosphonic acids containing sulfur substituents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Dinatriumtiludronattetrahydrat for anvendelse i farmasøytiske preparater for oral administrasjon i form av en tablett, brusende preparat, kapsel og lignende.
NO975634A 1995-06-08 1997-12-04 Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater NO975634L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/488,986 US5656288A (en) 1995-06-08 1995-06-08 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
PCT/US1996/008790 WO1996041618A1 (en) 1995-06-08 1996-06-04 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions

Publications (2)

Publication Number Publication Date
NO975634D0 NO975634D0 (no) 1997-12-04
NO975634L true NO975634L (no) 1998-01-29

Family

ID=23941935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975634A NO975634L (no) 1995-06-08 1997-12-04 Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater

Country Status (11)

Country Link
US (1) US5656288A (no)
EP (1) EP0831789A1 (no)
JP (1) JPH11507924A (no)
AR (1) AR003434A1 (no)
AU (1) AU5980896A (no)
BR (1) BR9609477A (no)
CA (1) CA2223568A1 (no)
MX (1) MX9709838A (no)
NO (1) NO975634L (no)
WO (1) WO1996041618A1 (no)
ZA (1) ZA964752B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
ATE256456T1 (de) * 1996-05-17 2004-01-15 Merck & Co Inc Biphosphonat-formulierung mit brausewirkung
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
BR0318460A (pt) * 2003-09-04 2006-09-12 Wockhardt Ltd sal de arginina de ácido benzoquinolizina-2-carboxìlico tetrahidratado
MXPA06003063A (es) * 2003-09-19 2006-05-31 Pfizer Prod Inc Composiciones farmaceuticas y metodos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina- d y un bisfosfonato.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
NO975634D0 (no) 1997-12-04
ZA964752B (en) 1997-01-13
EP0831789A1 (en) 1998-04-01
MX9709838A (es) 1998-08-30
JPH11507924A (ja) 1999-07-13
AU5980896A (en) 1997-01-09
US5656288A (en) 1997-08-12
WO1996041618A1 (en) 1996-12-27
CA2223568A1 (en) 1996-12-27
BR9609477A (pt) 1999-05-25
AR003434A1 (es) 1998-08-05

Similar Documents

Publication Publication Date Title
MY128809A (en) Pharmaceutical formulation of omeprazole
UA63993C2 (uk) Фармацевтична лікарська форма, що швидко тане в роті (варіанти) та спосіб формування гранул
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
PL341055A1 (en) Novel form of a drug for oral administration of active compounds being unstable in acid environments
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
AU6136199A (en) Dosage form comprising therapeutic formulation
IS3957A (is) Aðferð til framleiðslu á þrýstingsúðasamsetningumtil inntöku lyfja með innöndun
MXPA01004547A (es) Administracion oral de analogos de adenosina.
NO974404D0 (no) Insufflasjonsbærer for medikamenter med kontrollert frigivelse
IS5526A (is) 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum
AU1534699A (en) Osmotic dosage form comprising first and second coats
MY118371A (en) Tetrahydrolipstatin containing compositions
NO20042565L (no) Orale farmasoytiske produkter inneholdende 17 beta-ostradiol-3-lavere alkanoat, fremgangsmater for administrering av disse og fremgangsmater for fremstilling derav
MY127350A (en) Flash-melt oral dose formulations
NO975634L (no) Stabile farmasöytiske preparater inneholdende tiludronathydrater og fremgangsmåte for fremstilling av farmasöytiske preparater
MXPA04003346A (es) Formulacion de dosis oral de disolucion instantanea.
IS4030A (is) Lyf, ætlað til inntöku, sem hefur bakteríueyðandiáhrif í maga, aðferð við framleiðslu þess og notkun
GB9814215D0 (en) Anti-inflammatory pharmaceutical formulations
ATE192435T1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
NO180450C (no) Farmasöytiske formuleringer og fremgangsmåte for fremstilling av form II diritromycin
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
EE9600050A (et) Meetod kinoloone sisaldavate oraalsete kompositsioonide valmistamiseks ja tablett kinoloonide oraalseks manustamiseks
JO1821B1 (en) New pharmaceutical product
NO964775L (no) Fast farmasöytisk adenosinholdig preparat
YU28404A (sh) Brzo topljiva formulacija za oralno doziranje